Skip to content
NEThard Premium

Immunoassays in Forensic Science: ELISA, RIA, FPIA, Lateral Flow and Case Analysis (UGC-NET Unit II)

Published:

Questions

30

Duration

30 min

Faculty-reviewed

0

Updated

17 May 2026

Score, per-question explanations and topic breakdown shown right after you submit.

About this mock

UGC-NET Forensic Science Paper II Unit II hard-band drill on advanced immunoassay theory and forensic casework: the molecular basis of antigen-antibody binding, monoclonal versus polyclonal antibody selection, the four major label chemistries (radioactive RIA, enzymatic ELISA and EMIT, fluorescent FPIA, chemiluminescent CLIA), competitive and sandwich formats, sensitivity and specificity trade-offs, and the cross-reactivity matrices that govern false positives in drugs-of-abuse screening. Each question walks the student through a casework scenario, a SAMHSA Mandatory Guidelines cut-off, or a cross-reacting compound (poppy-seed morphine for opiates, dextromethorphan for PCP, Vicks l-methamphetamine for amphetamine, NSAIDs and pseudoephedrine for structural mimics) and tests the confirmatory analysis requirement under SAMHSA, ASB / SOFT, and the NDPS Act analytical chain.

Designed for UGC-NET Paper II aspirants, NFSU MSc Forensic Science students, and FACT candidates revising serology and toxicology immunoassays. Hard-band distractors differ from the correct answer on a single subsection, a single numerical cut-off, or a single mechanistic step, so the student must know the precise SAMHSA threshold, the specific antibody cross-reactivity, and the right confirmatory technique rather than the broad concept.

Topics covered:

  • Antigen-antibody binding kinetics and antibody selection for forensic immunoassays
  • Label chemistries: radioactive (RIA), enzymatic (ELISA, EMIT), fluorescent (FPIA), chemiluminescent (CLIA)
  • Competitive versus sandwich formats and when each applies
  • SAMHSA Mandatory Guidelines cut-offs for cannabinoids, opiates, amphetamines, cocaine and PCP
  • Cross-reactivity matrices and structural-mimic false positives in drugs-of-abuse screening
  • Forensic biological assays: Hexagon OBTI, ABAcard p30, RSID-Saliva, ABAcard HemaTrace
  • Species identification by precipitin and ELISA with anti-human antibodies
  • Confirmatory testing under SAMHSA, ASB / SOFT guidelines, and the NDPS Act analytical chain

Calibrated for serious UGC-NET preparation in the run-up to the next cycle and aligned with the current Paper II Unit II syllabus references to immunological techniques, serology, and forensic toxicology.

Allow 30 minutes.

Sources & references

Questions in this mock are written and verified against the following sources. Citations are recorded per question and shown in the explanation after submission.

  • Moeller K.E., Kissack J.C., Atayee R.S., Lee K.C., Clinical Interpretation of Urine Drug Tests, Mayo Clin Proc 2017; 92(5):774

    Methamphetamine cross-reactivity and the Vicks-inhaler licit-use defence; chiral GC-MS resolution

    Open source
    cited in 3 questions
  • SAMHSA Mandatory Guidelines for Federal Workplace Drug Testing Programs (Urine), 82 FR 7920

    Section 3.5: opiate confirmation cut-off 2000 ng/mL; separate 6-acetylmorphine cut-off 10 ng/mL for heroin proof

    Open source
    cited in 2 questions
  • Old J.B., Schweers B.A., Boonlayangoor P.W., Reich K.A., Developmental validation of RSID-Saliva, J Forensic Sci 2009; 54:866

    Validation of Rapid Stain Identification of Saliva (RSID-Saliva) targeting human salivary alpha-amylase AMY1

    Open source
    cited in 1 question
  • ASB Standard 036, Standard for Method Validation in Forensic Toxicology; SOFT/AAFS Forensic Toxicology Laboratory Guidelines 2006

    Confirmation requirements: GC-MS or LC-MS/MS, retention-time and ion-ratio criteria, reference-standard traceability

    Open source
    cited in 1 question
  • NDPS Act 1985 and Narcotics Control Bureau Standing Order 1/89; DFSS, MHA, Forensic Toxicology Quality Manual

    Indian analytical framework for drugs-of-abuse casework; chain of custody and confirmation requirements

    Open source
    cited in 1 question
  • Smith M.L., Cone E.J., Drugs of Abuse Testing: Interpretation and Pitfalls, in Levine B. (ed.), Principles of Forensic Toxicology, 5th Edition

    Cross-reactivity of opiate immunoassays and the oxycodone false-negative problem

    cited in 1 question
  • Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 6th Edition

    Immunochemical Techniques, competitive versus sandwich ELISA, format selection by analyte size

    cited in 1 question
  • SAMHSA Mandatory Guidelines for Federal Workplace Drug Testing Programs (Oral Fluid), 84 FR 57554 (2019)

    Oral-fluid initial-test and confirmatory cut-offs; DRUID project comparators

    Open source
    cited in 1 question
  • Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 6th Edition (Rifai N, ed.)

    Chapter on Immunochemical Techniques, antibody affinity and immunoassay design

    cited in 1 question
  • NDPS Act, 1985, Section 52A, read with Union of India v. Mohanlal, (2016) 3 SCC 379

    Mandatory sampling procedure before Magistrate; FSL analytical chain through immunoassay screen and GC-MS confirmation

    Open source
    cited in 1 question
  • Johnston E., Ames C.E., Dagnall K.E., Foster J., Daniel B.E., Comparison of presumptive blood test kits including Hexagon OBTI, J Forensic Sci 2008; 53(3):687

    Validation of Hexagon OBTI human-haemoglobin lateral-flow immunoassay for forensic stain identification

    Open source
    cited in 1 question
  • Yalow R.S., Berson S.A., Immunoassay of endogenous plasma insulin in man, J Clin Invest 1960; 39:1157

    Foundational paper on radioimmunoassay; competitive heterogeneous format with 125I tracer

    Open source
    cited in 1 question
  • SAMHSA Mandatory Guidelines for Federal Workplace Drug Testing Programs (Urine), revised effective 1998 and consolidated in 82 FR 7920

    Section 3.4 to 3.5: opiate cut-off raised to 2000 ng/mL; separate 6-acetylmorphine cut-off at 10 ng/mL

    Open source
    cited in 1 question
  • Cone E.J., Welch P., Mitchell J.M., Paul B.D., Forensic drug testing for opiates: poppy-seed urine, J Anal Toxicol 1991; 15:1

    Computation of morphine-equivalent immunoassay signal from cross-reactivity matrix; SAMHSA cut-off implications

    cited in 1 question
  • Hochmeister M.N., Budowle B., Rudin O. et al., Evaluation of prostate-specific antigen (PSA) membrane test assays for the forensic identification of seminal fluid, J Forensic Sci 1999; 44:1057

    Validation of ABAcard p30 lateral-flow PSA test for forensic seminal-fluid identification

    Open source
    cited in 1 question
  • Huestis M.A., Mitchell J.M., Cone E.J., Detection times of marijuana metabolites in urine by immunoassay and GC-MS, J Anal Toxicol 1995; 19:443

    Window of detection for THC-COOH in urine in chronic heavy users versus occasional users

    cited in 1 question
  • SAMHSA Mandatory Guidelines for Federal Workplace Drug Testing Programs (Urine), Final Rule, 82 FR 7920

    Section 3.4 to 3.5: Validity testing and initial test analytes; cross-reactivity documentation

    Open source
    cited in 1 question
  • Directorate of Forensic Science Services (DFSS), MHA, Quality Manual for Toxicology Section, CFSLs

    Two-tier workflow for narcotics analysis: immunoassay screening followed by GC-MS or LC-MS/MS confirmation

    Open source
    cited in 1 question
  • Weeks I., Beheshti I., McCapra F., Campbell A.K., Woodhead J.S., Acridinium esters as high-specific-activity labels in immunoassay, Clin Chem 1983; 29:1474

    Foundational paper on acridinium ester chemiluminescence in immunoassay

    cited in 1 question
  • SD Bioline Multi-Drug Urine Test Cassette package insert (Abbott Diagnostics, Standard Diagnostics)

    Competitive lateral-flow read interpretation: test line present below cut-off, absent at or above cut-off

    cited in 1 question
  • Posthuma-Trumpie G.A., Korf J., van Amerongen A., Lateral-flow (immuno)assay: its strengths, weaknesses, opportunities, Anal Bioanal Chem 2009; 393:569

    Operational comparison of lateral-flow immunoassays and plate ELISA in diagnostic and forensic biology workflows

    Open source
    cited in 1 question
  • Rubenstein K.E., Schneider R.S., Ullman E.F., Homogeneous enzyme immunoassay, Biochem Biophys Res Commun 1972; 47:846

    Foundational EMIT paper, glucose-6-phosphate dehydrogenase conjugate format

    cited in 1 question
  • Schweers B.A., Old J., Boonlayangoor P.W., Reich K.A., Developmental validation of a fluorescence-detected immunoassay, J Forensic Sci 2008; 53(1):104

    Lateral-flow sandwich immunoassay limitations, high-dose hook effect at saturating antigen concentration

    Open source
    cited in 1 question
  • Levine B. (ed.), Principles of Forensic Toxicology, 5th Edition, AACC Press

    Chapter on Drugs-of-Abuse Testing: design philosophy of screening immunoassays and the role of mass-spectrometric confirmation

    cited in 1 question
  • Dandliker W.B., Feigen G.A., Quantification of the antigen-antibody reaction by the polarisation of fluorescence, Biochem Biophys Res Commun 1961; 5:299

    Foundational fluorescence polarisation immunoassay paper; basis of the Abbott TDx platform

    cited in 1 question
  • Saferstein R., Criminalistics: An Introduction to Forensic Science, 12th Edition

    Chapter on Forensic Serology, Uhlenhuth precipitin test and species identification by ELISA

    cited in 1 question
  • National Institute of Biologicals (NIB), Noida, official mandate, Ministry of Health and Family Welfare

    National reference laboratory for vaccines, sera, and immunoassay reagents

    Open source
    cited in 1 question

How our mocks are built

Questions are written and edited by the ForensicSpot team and cited from peer-reviewed forensic textbooks, official syllabi and primary case law. Each one is verified before publishing. Detailed explanations show after you submit, so the test stays a real test. See a mistake? Tell us.

Common questions

What does the Immunoassays in Forensic Science: ELISA, RIA, FPIA, Lateral Flow and Case Analysis (UGC-NET Unit II) mock cover?+

UGC-NET Forensic Science Paper II Unit II hard-band drill on advanced immunoassay theory and forensic casework: the molecular basis of antigen-antibody binding, monoclonal versus polyclonal antibody selection, the four major label chemistries (radioactive RIA, enzymatic ELISA and EMIT, fluorescent FPIA, chemiluminescent CLIA), competitive and sandwich formats, sensitivity and specificity trade-offs, and the cross-reactivity matrices that govern false positives in drugs-of-abuse screening. Each q

How many questions and how long is the test?+

30 multiple-choice questions, 30 minutes total. Difficulty: hard. Tier: Premium.

Who is this mock for?+

Forensic science students and aspirants who want timed, exam-style practice with explanations and verified source citations on NET. Useful for postgraduate entrance preparation and for BSc / MSc forensic students testing their recall under time.

Are the questions reviewed?+

Each question carries a verified source citation. Faculty review for individual questions is in progress.

Do I need an account to take this mock?+

Yes, a free ForensicSpot account is required to start a timed attempt — this lets you save progress, see per-question explanations after submission, and track your topic-level performance over time.

Your journey to becoming a forensic professional starts here.

Practice with mock tests, learn from structured notes, and get your questions answered by a global forensic community, all in one place.